TB and COVID-19, a joint battle?
On World TB Day 2022, we are looking at how researchers from the McGill International TB Centre at the RI-MUHC are working to raise awareness and to put an end to TB.
RI-MUHC team receives Discovery of the Year Award from Québec Science magazine
Jean-Jacques Lebrun’s team at the RI-MUHC has won the 2021 Québec Science Discovery of the Year Award...
Cecilia Costiniuk receives 2022 CAHR-CANFAR Excellence in Research Award
RI-MUHC researcher is committed to improving the lives of those living with HIV
RI-MUHC trainee honoured by the American Association for Cancer Research
Yasmine Benslimane is investigating how the female hormone estrogen influences the spread of colon cancer...
LSD, a future antianxiety pill?
A new study by Dr. Gabriella Gobbi reveals the neurobiological mechanisms by which LSD could relieve anxiety
BCG vaccine provides protection against influenza virus but not SARS-CoV-2
A new study led by RI-MUHC researchers reveals that the 100-year-old tuberculosis vaccine known as..
What’s the signature of a healthy heart?
Instead of treating the “average person,” the Courtois Cardiovascular Signature Program aims to treat every person as a unique individual
COVID-19: A close look at vaccine strategies used with older people in Quebec
A new study determines the maximum recommended interval between the first and second doses of mRNA...
Beyond basic research: Coming to grips with a rare disease experience
To honour Rare Disease Day on February 28, an RI-MUHC research trainee shares the perspective he gained as a patient
CTN study tests new drug for the first time in people living with HIV
Postdoc Léna Royston aims to understand how cytomegalovirus infection can increase inflammation and cause health issues